Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Codexis Inc (NASDAQ: CDXS) closed at $4.52 up 2.96% from its previous closing price of $4.39. In other words, the price has increased by $2.96 from its previous closing price. On the day, 0.73 million shares were traded. CDXS stock price reached its highest trading level at $4.57 during the session, while it also had its lowest trading level at $4.24.
Ratios:
For a deeper understanding of Codexis Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.15 and its Current Ratio is at 3.21. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.51.
On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 30 ’24 when Opaleye Management Inc. bought 35,000 shares for $4.70 per share. The transaction valued at 164,392 led to the insider holds 8,580,000 shares of the business.
Opaleye Management Inc. bought 10,000 shares of CDXS for $46,603 on Dec 31 ’24. The 10% Owner now owns 8,590,000 shares after completing the transaction at $4.66 per share. On Oct 25 ’24, another insider, Opaleye Management Inc., who serves as the 10% Owner of the company, bought 25,000 shares for $2.91 each. As a result, the insider paid 72,720 and bolstered with 8,545,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 367828128 and an Enterprise Value of 319418912. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.71 while its Price-to-Book (P/B) ratio in mrq is 5.01. Its current Enterprise Value per Revenue stands at 4.956 whereas that against EBITDA is -6.977.
Stock Price History:
The Beta on a monthly basis for CDXS is 2.14, which has changed by 0.6199262 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $6.08, while it has fallen to a 52-week low of $2.53. The 50-Day Moving Average of the stock is -2.22%, while the 200-Day Moving Average is calculated to be 28.24%.
Shares Statistics:
For the past three months, CDXS has traded an average of 687.87K shares per day and 593800 over the past ten days. A total of 81.38M shares are outstanding, with a floating share count of 79.18M. Insiders hold about 2.70% of the company’s shares, while institutions hold 77.66% stake in the company. Shares short for CDXS as of 1734048000 were 1901861 with a Short Ratio of 3.34, compared to 1731628800 on 1680708. Therefore, it implies a Short% of Shares Outstanding of 1901861 and a Short% of Float of 2.6099999.
